Hepatitis B Vaccine (HBV) for children and adults 2023-2025 (2025-2026, 2026-2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years 2023-2025. The procurement contains two options to extend the contract for the periods 2025-2026 and 2026-2027.

The purpose of STM and the Customer is to procure Hepatitis B Vaccines for children and adults required for the National Vaccination Programme in Finland for risk groups. The tendered vaccine for children must be suitable for children aged 0-15 years. The tendered vaccine for adolescents and adults must be suitable for people aged 16 years and over. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/hepatitis-vaccines/hepatitis-b-vaccine The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as in this Call for Tender and its Annexes.